Recently, increasing evidence has shown that GSK-3β may be a key link between diabetes mellitus (DM) and Alzheimer’s disease (AD), where GSK-3β controls glycogen synthesis, thereby regulating blood glucose [26]. Here, GSK3B is linked to diabetes mellitus.